Department of Digestive and Endocrine Surgery, Cochin Hospital, APHP, Paris, France; Paris Descartes University, Paris, France.
Service D'Hépato-gastro-entérologie, CHU Dupuytren, Limoges, France; Faculté de Médecine de Limoges, Limoges, France.
HPB (Oxford). 2021 Jan;23(1):154-160. doi: 10.1016/j.hpb.2020.06.001. Epub 2020 Jul 6.
After ERCP failure or if ERCP is declined for preoperative biliary drainage before pancreaticoduodenectomy, endoscopic ultrasound-guided choledochoduodenostomy (EUS-CDS) with electrocautery-enhanced lumen-apposing stents (ECE-LAMS) might be needed. The aim of the present study was to assess the technical feasibility and short-term outcomes of pancreaticoduodenectomy (PD) following endoscopic ultrasound-guided choledochoduodenostomy (EUS-CDS) with electrocautery-enhanced lumen-apposing stents (ECE-LAMS).
A retrospective study of all EUS-CDS procedures with ECE-LAMS followed by PD performed in France since the availability of the device in 2016.
21 patients underwent PD in 9 departments of surgery following EUS-CDS with ECE-LAMS. The median bilirubin level at endoscopic procedure was 292 μmol/L. A 6 mm diameter stent was used in 20 cases. No complications occurred during the procedure. During the waiting time, 1 patient had an acute pancreatitis post ERCP and 3 patients developed cholangitis, treated by either an additional percutaneous biliary drainage, or an endoscopic procedure to extract a bezoar occluding the stent, or antibiotics, respectively. PD with a curative intent was performed in all cases. Overall, postoperative mortality was nil and postoperative morbidity occurred in 17 patients (81%), including 3 with severe complications (14%). No patient developed postoperative biliary fistula. In the 21 patients followed at least 6 months, no biliary complications occurred, and no tumor recurrence developed on the hepaticojejunostomy/hepatic pedicle.
Pancreaticoduodenectomy following EUS-CDS with ECE-LAMS is technically feasible with acceptable short-term postoperative outcome, including healing of biliary anastomosis.
在 ERCP 失败或在胰十二指肠切除术前行术前胆道引流时拒绝 ERCP 的情况下,可能需要进行内镜超声引导下胆肠吻合术(EUS-CDS)联合电切增强型吻合支架(ECE-LAMS)。本研究旨在评估内镜超声引导下胆肠吻合术(EUS-CDS)联合电切增强型吻合支架(ECE-LAMS)后行胰十二指肠切除术(PD)的技术可行性和短期结果。
这是一项回顾性研究,纳入了自 2016 年该设备上市以来在法国进行的所有 EUS-CDS 联合 ECE-LAMS 后行 PD 的患者。
9 个外科部门的 21 例患者在 EUS-CDS 联合 ECE-LAMS 后行 PD。内镜操作时胆红素中位数为 292μmol/L。20 例患者使用了 6mm 直径的支架。操作过程中无并发症发生。在等待期间,1 例患者在 ERCP 后发生急性胰腺炎,3 例患者发生胆管炎,分别通过额外的经皮胆道引流、内镜取出支架阻塞物或抗生素治疗。所有患者均行根治性 PD。总的来说,术后死亡率为零,17 例(81%)患者发生术后并发症,包括 3 例严重并发症(14%)。无患者发生术后胆瘘。在至少随访 6 个月的 21 例患者中,无胆道并发症发生,肝肠吻合口/肝蒂无肿瘤复发。
EUS-CDS 联合 ECE-LAMS 后行 PD 技术上可行,短期术后结果可接受,包括胆肠吻合口愈合。